720 related articles for article (PubMed ID: 19076841)
1. New developments in carbapenems.
Kattan JN; Villegas MV; Quinn JP
Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
[TBL] [Abstract][Full Text] [Related]
2. Carbapenems: a potent class of antibiotics.
Nicolau DP
Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
[TBL] [Abstract][Full Text] [Related]
3. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ; Lancaster JW
Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
[TBL] [Abstract][Full Text] [Related]
4. The use of carbapenems in the treatment of serious infections.
Baughman RP
J Intensive Care Med; 2009; 24(4):230-41. PubMed ID: 19617229
[TBL] [Abstract][Full Text] [Related]
5. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Joseph J; Rodvold KA
Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
7. [Available carbapenems: Properties and differences].
Martínez MJ; García MI; Sánchez EG; Sánchez JE
Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():53-64. PubMed ID: 21130931
[TBL] [Abstract][Full Text] [Related]
8. Doripenem: position in clinical practice.
Dedhia HV; McKnight R
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
[TBL] [Abstract][Full Text] [Related]
9. Parenteral carbapenems.
Shah PM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
[TBL] [Abstract][Full Text] [Related]
10. What's new on the antimicrobial horizon?
Song JH
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
[TBL] [Abstract][Full Text] [Related]
11. Comparative review of the carbapenems.
Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
[TBL] [Abstract][Full Text] [Related]
12. Carbapenems in the USA: focus on doripenem.
Lister PD
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):793-809. PubMed ID: 17914914
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
Nicolau DP; Carmeli Y; Crank CW; Goff DA; Graber CJ; Lima AL; Goldstein EJ
Int J Antimicrob Agents; 2012 Jan; 39(1):11-5. PubMed ID: 22047702
[TBL] [Abstract][Full Text] [Related]
14. Doripenem.
Paterson DL; Depestel DD
Clin Infect Dis; 2009 Jul; 49(2):291-8. PubMed ID: 19527173
[TBL] [Abstract][Full Text] [Related]
15. Doripenem (Doribax)--a new parenteral carbapenem.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
[No Abstract] [Full Text] [Related]
16. Doripenem: an early look at a carbapenem not yet approved for pediatrics.
Overturf GD
Pediatr Infect Dis J; 2010 Feb; 29(2):163-5. PubMed ID: 20135831
[No Abstract] [Full Text] [Related]
17. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.
Miller AD; Ball AM; Bookstaver PB; Dornblaser EK; Bennett CL
Pharmacotherapy; 2011 Apr; 31(4):408-23. PubMed ID: 21449629
[TBL] [Abstract][Full Text] [Related]
18. Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.
Slama TG
Crit Care; 2008; 12(5):233. PubMed ID: 18983709
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
Rahal JJ
Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.
Vergidis PI; Falagas ME
Curr Opin Investig Drugs; 2008 Feb; 9(2):176-83. PubMed ID: 18246520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
